Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference

N. Billerica, MA – Seahorse Bioscience, Inc., the leading manufacturer of instruments and consumables for measuring cellular metabolism announced today that Chief Executive Officer, Jay Teich, will present at the 2010 UBS Global Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. EDT at the Grand Hyatt Hotel in New York City. Mr. Teich will highlight the company's strategy for maintaining rapid growth of 85% CAGR in a new $1BB Life Science Cellular Bioenergetics market. "We believe that we are at the right place at the right time to ride a wave of interest in cell bioenergetics as it applies to Cancer, Obesity, Diabetes, Ageing and Cardiovascular function" proclaimed Mr. Teich.

A live webcast of the conference can be viewed at UBS Global Life Sciences Conference.

About Seahorse Bioscience

Seahorse XF instruments have become the new standard in cellular bioenergetic measurements. Over 450 scientists worldwide are advancing their research in understanding the role of cellular bioenergetics in Aging, Cancer, Cardiovascular, Cell Physiology, Toxicology & Hepatobiology, Immunology, Infectious Diseases, Mitochondrial Diseases, Model Organisms, Neurodegeneration, Obesity, Diabetes, & Metabolic Disorders, Screening, and Translational Medicine. Founded in 2001, Seahorse is headquartered in Billerica, MA.